CLINICAL LABORATORY, vol.68, no.6, pp.1245-1250, 2022 (SCI-Expanded)
Background: In our study, we evaluated the in vitro activities of plazomicin, amikacin, gentamicin, and tobramycin among fifty carbapenem resistant Klebsiella pneumoniae (CR-Kp) isolates. Aminoglycoside resistance genes in selected CR-Kp strains were also examined.